420 
Progress  in  Pharmacy. 
( Am.  Jour.  Pharm. 
t  September,  1914. 
Patent  Medicines.  {Anon.) — -Our  Parliamentary  correspondent 
learns  that  a  further  prolonged  sitting  of  the  Select  Committee  on 
Patent  and  Proprietary  Medicines  was  held  on  Tuesday  at  the  House 
of  Commons.  Sir  Henry  Norman,  the  Chairman,  again  presided. 
Altogether,  the  meeting  lasted  for  some  hours,  and,  as  the  result, 
about  one-half  of  the  draft  report  has  now  been  disposed  of. — Chem. 
and  Drug.,  1914,  vol.  85,  p.  223. 
Consumption  Cure.  (Editorial.) — After  a  hearing  extending 
over  seven  days,  the  libel  action  against  the  British  Medical  Associa- 
tion brought  by  Mr.  C.  H.  Stevens,  the  proprietor  of  "  Stevens' 
Consumption  Cure,"  has  terminated  in  a  verdict  for  the  defendants. 
The  jury,  after  an  absence  of  about  10  minutes,  found  the  matter 
complained  of  was  of  the  nature  of  fair  comment  and  judgment  was 
accordingly  given  in  favor  of  the  British  Medical  Association. — 
Pharm.  J.,  1914,  vol.  93,  p.  191. 
Proprietary  Remedies.  (Editorial.) — The  drug  fund  of  the 
London  Insurance  Committee  is  threatened  by  the  over-prescribing 
of  proprietaries  and  the  drugs  and  appliances  sub-committee  of  the 
Insurance  Committee  has  issued  a  list  of  articles  as  not  being 
"  proper  and  sufficient  drugs  and  medicines  and  prescribed  ap- 
pliances required  to  be  provided  for  insured  persons,"  under  the 
National  Insurance  Act. — Chem.  and  Drug.,  1914,  vol.  85,  p.  221. 
National  Insurance  Pharmacopoeia. — kt  Karshish  "  suggests  the 
adoption  of  a  national  insurance  pharmacopoeia  to  avoid  unnecessary 
deficiencies  in  the  drug  fund. — Pharm.  J.,  1914,  vol.  93,  p.  11. 
British  Pharmacopoeia.  (London  Letter.) — The  work  of  prepar- 
ing a  new  edition  of  the  British  Pharmacopoeia  has  now  been  com- 
pleted. One  of  the  chief  features  will  be  that  limits  of  impurity  in 
drugs  and  medicinal  chemicals — especially  dangerous  impurity — 
will  be  carefully  defined.  Another  feature  of  the  book  is  an  ex- 
tension of  chemical  standardization  to  drugs  not  at  present  standard- 
ized, but  there  is  no  recognition  of  physiologic  standardization. 
The  international  unification  of  the  quality  of  preparations  of  potent 
drugs,  which  has  received  the  endorsement  of  various  nations,  has  due 
recognition  in  the  forthcoming  book. — /.  Am.  M.  Assoc.,  1914,  vol. 
62,  p.  2039. 
British  Pharmacopoeia.  (Editorial.) — At  its  meeting  on  July  13 
the  Executive  Committee  of  the  General  Medical  Council  formally 
adopted  the  completed  draft  of  the  British  Pharmacopoeia,  1914,  as 
submitted  by  the  Pharmacopoeia  Committee.    It  was  resolved  that 
